SAYKI, M. Et Al. 2014. The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoporosis in Patients with Prolactinoma. Endocrine Society's 96th Annual Meeting and Expo , (Chicago, United States Of America).

SAYKI, M., ŞAHİN, M., TUTAL AKKAYA, E., Karakose, M., TOPALOĞLU, O., UÇAN, B., ... DEMİRCİ, T.(2014). The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoporosis in Patients with Prolactinoma . Endocrine Society's 96th Annual Meeting and Expo, Chicago, United States Of America

SAYKI, MÜYESSER Et Al. "The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoporosis in Patients with Prolactinoma," Endocrine Society's 96th Annual Meeting and Expo, Chicago, United States Of America, 2014

SAYKI, MÜYESSER Et Al. "The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoporosis in Patients with Prolactinoma." Endocrine Society's 96th Annual Meeting and Expo , Chicago, United States Of America, 2014

SAYKI, M. Et Al. (2014) . "The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoporosis in Patients with Prolactinoma." Endocrine Society's 96th Annual Meeting and Expo , Chicago, United States Of America.

@conferencepaper{conferencepaper, author={MÜYESSER SAYKI Et Al. }, title={The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoporosis in Patients with Prolactinoma}, congress name={Endocrine Society's 96th Annual Meeting and Expo}, city={Chicago}, country={United States Of America}, year={2014}}